Overview
February 22: Ad Promo Primer*
February 23-24: Conference
*Primer requires separate registration.
DIA’s Advertising and Promotions Regulatory Affairs Conference, formerly known as the DIA Marketing Pharmaceutical Conference, has a comprehensive agenda covering the latest updates in the ad promo regulatory space. You will participate in discussions on the new and emerging industry trends as well as examine and analyze new FDA guidances and initiatives. This conference will provide you with the opportunity to network with regulatory and legal professionals, as well as industry leaders in advertising and promotion. Whether you’re just starting out or have years of expertise and knowledge, this conference can be customized to meet your needs!
Approved by the Regulatory Affairs Professionals Society for 12 RAC credits.
Schedule At-A-Glance
Session 1: FDA: Focus on New Initiatives Enforcement
Session 2: FDA Draft Guidance and Initiatives
Session 3: OPDP Research Agenda
Session 4A: Considerations for Expanding Proactive Communications by Biopharmaceutical Manufacturers to Population Health Decision Makers -or- Session 4B: Deep Dive: Live and Field-Based Tactics
Session 6: Question and Answer Session with FDA
Session 7: Mobile Apps – When Are They Promotions, When Are They Regulated Devices?
Session 8A: Ad-Promo's Role in the Adoption of Technology across the Organization -or- Session 8B: Deep Dive: Digitial Tactics
Session 9A: Considerations for Developing a Productive Advertising and Promotion Team -or- Session 9B: Building Bridges: Creating and Maintaining a Productive Relationship with FDA on Advertising and Promotion Issues
Session 10: Patient Support Programs
Featured
Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!
Program Committee
-
Thomas W. Abrams, MBA, RPh Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Former FDA, United States -
Glenn N. Byrd, MBA President
GByrd Ad-Promo Solutions, LLC, United States -
Dale Cooke, JD, MA President
PhillyCooke Consulting , United States -
Mark Gaydos Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States -
Tracy Rockney, JD Co-Founder and Managing Partner
Onesource Regulatory, United States -
Paul Savidge, JD, MBA Senior Regulatory Counsel
Spark Therapeutics, Inc., United States -
Michele Sharp, PharmD Senior Director, Global Regulatory Affairs
Eli Lilly and Company, United States -
Wayne Pines President, Health Care
United States -
Lucy Rose, MBA President
Lucy Rose and Associates, United States
Have an account?